PCK1 and schizophrenia: As we cannot draw firm conclusions with the current data further investigations with testing of more loci are required to clarify whether ENO2, FBP1, MAPK14 and PCK1 variants provide genetic support for the view that alterations in glucose metabolism are intrinsic to schizophrenia etiology.